EARLY Labs
@earlylabs.io
With a new approach to VOC biomarkers Early will revolutionize the way cancer is detected and treated Our novel proprietary multi-cancer screening platform will create value for all stakeholders, across the screening and treatment pipeline
EARLY Labs's Company Logos
EARLY Labs's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#3273DC
Royal Blue
50, 115, 220
217, 71, 53
77, 48, 0, 14
#B3D4FC
Sail
179, 212, 252
213, 92, 85
29, 16, 0, 1
#101828
Ebony
16, 24, 40
220, 43, 11
60, 40, 0, 84
About EARLY Labs
EARLY is a pioneering brand that aims to revolutionize cancer detection and treatment through a new approach to VOC biomarkers. With a focus on making cancer screening a right rather than a privilege, EARLY has developed a novel multi-cancer screening platform called the Biosensor Platform (BSP) Urine Test. This proprietary platform is designed to be accurate, safe, non-invasive, simple, cost-effective, and accessible to people worldwide, beginning with lung cancer.
By utilizing a single urine test, EARLY's platform can detect cancer at its earliest stages, enabling more treatment options and significantly increasing patients' chances of survival and quality of life. The platform offers a range of benefits, including safety, accuracy, simplicity, and affordability. EARLY's mission is to reduce the global human and financial burden of cancer by providing diagnostic-level testing on a large scale.
With a team of highly experienced experts in biology, zoology, engineering, bioinformatics, and marketing, EARLY is dedicated to transforming the way cancer is detected and treated
